Logotype for WuXi Biologics (Cayman) Inc

WuXi Biologics (2269) investor relations material

WuXi Biologics H1 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for WuXi Biologics (Cayman) Inc
H1 2025 earnings summary20 Aug, 2025

Executive summary

  • Revenue grew 16.1% year-over-year to nearly RMB10 billion in H1 2025, driven by robust project wins, expanded service offerings, and global client base, with a record 86 new projects added.

  • Net profit surged 54.8% year-over-year to RMB2,756.6 million, with net profit margin improving to 27.7%.

  • Backlog reached US$20.3 billion as of June 30, 2025, supporting future growth and revenue visibility.

  • Commercial and late-phase manufacturing projects grew significantly, now representing over 43% of the portfolio, with strong focus on ADCs and multispecifics.

  • North America contributed 60.5% of revenue, with Asia and Rest of World showing strong growth.

Financial highlights

  • Gross profit increased 27.0% year-over-year to RMB4,252.9 million; gross margin expanded to 42.7%.

  • Adjusted EBITDA rose 20.5% to RMB4,305.2 million, with margin at 43.3%.

  • Adjusted net profit reached RMB2,840.0 million, up 11.6% year-over-year.

  • Basic EPS increased 56.8% to RMB0.58 per share; diluted EPS up 57.1% to RMB0.55.

  • Free cash flow was near break-even in H1, with substantial improvement expected in H2.

Outlook and guidance

  • Full-year 2025 revenue growth target raised to 14–16%, with improved profitability and record free cash flow expected.

  • Anticipates continued acceleration in project wins, manufacturing, and IP-driven revenue, supported by global expansion and technology innovation.

  • Focus on enhancing integrated platform, capacity optimization, and operational excellence.

IP-driven revenue: What's 5-year profit contribution?
China revenue decline: How does out-licensing offset?
Continuous processing: What's its capacity impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next WuXi Biologics earnings date

Logotype for WuXi Biologics (Cayman) Inc
H2 202525 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next WuXi Biologics earnings date

Logotype for WuXi Biologics (Cayman) Inc
H2 202525 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

WuXi Biologics (Cayman) Inc. is a global contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company offers comprehensive services that span from biologic discovery and development to commercial manufacturing. Key offerings include protein generation, antibody development, assay development, and regulatory affairs. The company is headquartered in Wuxi, China, and its shares are listed on the Hong Kong Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage